Page last updated: 2024-09-03

imatinib mesylate and Cancer of Duodenum

imatinib mesylate has been researched along with Cancer of Duodenum in 37 studies

Research

Studies (37)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	13 (35.14)	29.6817
2010's	19 (51.35)	24.3611
2020's	5 (13.51)	2.80

Authors

Authors	Studies
Aghmesheh, M; Daly, D; Gandy, R; Goldstein, D; Symons, R	1
Adachi, S; Akagi, K; Andou, H; Douno, K; Hirota, M; Imamura, H; Iwazawa, T; Kawase, T; Nagase, H; Noguchi, K; Noura, S; Oshima, K; Taguchi, T; Tamura, Y; Tanida, T	1
Lin, TY; Qian, HR	1
Ikeda, M; Inoue, M; Kajikawa, R; Kajiwara, R; Miyamoto, K; Ohmori, I; Sadamoto, S; Sawada, H; Shishida, M; Takahashi, T; Toyota, K; Watanabe, A	1
Arkhiri, PP; Filonenko, DA; Kolobanova, ES; Meshcheryakov, AA; Nered, SN; Nikulin, MP; Stilidi, IS; Yugay, VV	1
Babić, N; Bohnec, S; Budimir, I; Hrabar, D; Nikolić, M; Pavić, I	1
Huang, ML; Li, C; Liu, WT; Sah, BK; Shi, HP; Wang, ZQ; Yan, M; Zheng, YN; Zhu, ZG; Zhu, ZL	1
Ishigame, T; Kase, K; Kenjo, A; Kimura, T; Kofunato, Y; Marubashi, S; Muto, M; Okada, R; Sato, N; Shimura, T; Watanabe, J	1
Haq, MI; Nixon, J; Stanley, AJ	1
He, D; Hou, Y; Hu, Q; Jiang, D; Liu, J; Liu, Y; Lu, S; Lu, W; Shi, Y; Tan, Y; Xu, C; Zhu, X	1
Ando, K; Ikeda, T; Ito, S; Kawanaka, H; Kawano, H; Kusumoto, T; Maehara, Y; Morita, M; Oki, E; Otsu, H; Saeki, H; Sakaguchi, Y; Soejima, Y; Sugimachi, K; Uchiyama, H	1
Fujikawa, T; Fukuyama, K; Kuramitsu, S; Tanaka, A	1
Chang, YR; Han, IW; Jang, JY; Kang, MJ; Kim, SW; Kwon, W; Lee, HJ; Lee, KB; Park, JW; Park, KJ	1
Fang, Y; Gao, X; Hou, Y; Li, H; Ling, J; Qin, J; Qin, X; Shen, K; Shu, P; Sun, Y; Xue, A	1
Egawa, C; Goto, T; Hashimoto, T; Ishida, T; Kagawa, Y; Kato, T; Katsura, Y; Kimura, K; Kuroda, Y; Kusama, H; Matsushita, K; Morimoto, Y; Nakahira, S; Nakatsuka, S; Nitta, K; Ohmura, Y; Ohzono, K; Okishiro, M; Sakisaka, H; Sato, Y; Takeda, Y; Takeno, A; Tamura, S; Taniguchi, H	1
Cisano, C; Crocetti, D; De Toma, G; Pedullà, G; Polistena, A; Sapienza, P; Tarallo, M; Venturini, L	1
Ben Slama, S; Bouraoui, S; Gharbi, L; Gharbi, W; Goutallier, C; Lahmar-Boufaroua, A; Manai, S; Mzabi-Regaya, S	1
Bassaly, B; Hecker, A; Hecker, B; Hirschburger, M; Janssen, H; Padberg, W; Schwandner, T	1
Al-Haddabi, IH; Al-Qadhi, H; Chopra, PJ; Machado, NO	1
Hosaka, S; Kawamoto, S; Yamashita, K; Yoshida, T	1
Hamasu, S; Jinzai, Y; Kanto, S; Kobayashi, A; Konishi, S; Manaka, D; Nishitai, R; Sakamoto, K; Uehara, M; Yasuhara, Y; Yokoyama, D; Yoshino, K	1
Cubillo, A; Salas, NR	1
Bylina, E; Colombo, C; Gronchi, A; Hohenberger, P; Miceli, R; Raut, CP; Ronellenfitsch, U; Rutkowski, P; Yuxin, Z	1
Cavallaro, G; D'Ermo, G; De Toma, G; Pedullà, G; Polistena, A	1
Bartholomew, DM; Burke, LH; Miller, LA; Wegge, J	1
Gräter, H	1
Hara, K; Inada, K; Matsuura, A; Nakamura, T; Ohashi, K; Ohno, R; Okubo, K; Sawaki, A; Shimizu, Y; Suzuki, T; Yamao, K	1
Higuchi, T; Matsumoto, T; Tate, G; Yamaguchi, M	1
Akisik, FM; Henley, JD; Rajesh, A; Rushing, DA; Rydberg, J; Sandrasegaran, K	1
Aschoff, AJ; Henne-Bruns, D; Kramer, K; Siech, M; Sträter, J	1
Fukuda, K; Hagiwara, A; Kin, S; Kuriu, Y; Miyagawa, K; Nakase, Y; Nakashima, S; Sagara, Y; Sakakura, C; Yamagishi, H; Yamaoka, N; Yoshikawa, T	1
Hagiwara, A; Kin, S; Miyagawa, K; Nakase, Y; Nakashima, S; Sagara, Y; Sakakura, C; Soga, K; Yamagishi, H; Yamaoka, N; Yoshikawa, T	1
Bustamante Z, M; Capetillo Fuentes, M; Carvajal H, C; Contreras P, JE; Iturra U, S; Justiniano P, JC; Lombardi S, J	1
Corless, CL; Davidson, R; Debiec-Rychter, M; Graham, J; Reid, R; White, JD	1
Asakawa, M; Esaki, M; Hamaguchi, T; Kajiwara, T; Kosuge, T; Nara, S; Sakamoto, Y; Shimada, K	1
Bergenfeldt, M; Krarup-Hansen, A; Ludvigsen, L; Mahdi, B; Toxvaerd, A	1
Hagiwara, A; Kumano, T; Mizuta, Y; Otsuji, E; Sagara, Y; Sakakura, C; Yamaoka, N	1

Reviews

4 review(s) available for imatinib mesylate and Cancer of Duodenum

Article	Year
Progress in the Treatment of Small Intestine Cancer. Current treatment options in oncology, 2023, Volume: 24, Issue:4 Topics: Adenocarcinoma; Antineoplastic Agents; Duodenal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Neuroendocrine Tumors	2023
Large duodenal gastrointestinal stromal tumor presenting with acute bleeding managed by a whipple resection. A review of surgical options and the prognostic indicators of outcome. JOP : Journal of the pancreas, 2011, Mar-09, Volume: 12, Issue:2 Topics: Acute Disease; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Duodenal Neoplasms; Fatal Outcome; Gastrointestinal Hemorrhage; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Pyrimidines	2011
Duodenal gastrointestinal stromal tumors: review on clinical and surgical aspects. International journal of surgery (London, England), 2012, Volume: 10, Issue:9 Topics: Antineoplastic Agents; Benzamides; Digestive System Surgical Procedures; Duodenal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Neoadjuvant Therapy; Piperazines; Pyrimidines	2012
[Tumors of the small intestine]. Praxis, 2002, Oct-09, Volume: 91, Issue:41 Topics: Adenocarcinoma; Adenoma; Adenomatous Polyposis Coli; Antineoplastic Agents; Benzamides; Clinical Trials as Topic; Diagnosis, Differential; Duodenal Neoplasms; Genetic Predisposition to Disease; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Risk	2002

Other Studies

33 other study(ies) available for imatinib mesylate and Cancer of Duodenum

Article	Year
[Gastric Gastrointestinal Stromal Tumor Appearing Nine Years after Resection of a Duodenal Gastrointestinal Stromal Tumor-A Case Report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2020, Volume: 47, Issue:1 Topics: Antineoplastic Agents; Drug Resistance, Neoplasm; Duodenal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms	2020
[Tough choice of surgical treatment for duodenal gastrointestinal stromal tumor: pancreaticoduodenectomy or local resection?] Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 2020, Sep-25, Volume: 23, Issue:9 Topics: Antineoplastic Agents; Combined Modality Therapy; Duodenal Neoplasms; Duodenum; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Minimally Invasive Surgical Procedures; Pancreaticoduodenectomy; Prognosis; Robotic Surgical Procedures	2020
A liver metastasis 7 years after resection of a low-risk duodenal gastrointestinal stromal tumor. Clinical journal of gastroenterology, 2021, Volume: 14, Issue:5 Topics: Duodenal Neoplasms; Duodenum; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Middle Aged	2021
[Gastrointestinal stromal duodenal tumors: diagnostic mistakes and modern approaches to treatment]. Khirurgiia, 2021, Issue:8 Topics: Duodenal Neoplasms; Duodenum; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Neoadjuvant Therapy	2021
Abdominal Ultrasound – The Leading Method in Duodenal Gist Diagnostics Acta clinica Croatica, 2017, Volume: 56, Issue:1 Topics: Adult; Antineoplastic Agents; Digestive System Surgical Procedures; Duodenal Neoplasms; Endoscopy, Digestive System; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Liver Neoplasms; Magnetic Resonance Spectroscopy; Maintenance Chemotherapy; Metastasectomy; Tomography, X-Ray Computed; Ultrasonography	2017
Clinicopathological and Prognostic Features of Surgical Management in Duodenal Gastrointestinal Stromal Tumors. Digestive surgery, 2018, Volume: 35, Issue:6 Topics: Adult; Aged; Anastomosis, Surgical; Antineoplastic Agents; Chemotherapy, Adjuvant; Disease-Free Survival; Duodenal Neoplasms; Duodenum; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunum; Kaplan-Meier Estimate; Male; Middle Aged; Mitotic Index; Neoadjuvant Therapy; Neoplasm Grading; Pancreaticoduodenectomy; Postoperative Complications; Retrospective Studies; Survival Rate; Tumor Burden; Young Adult	2018
[A Case of Long-Term Survival of Metastatic and Recurrent Duodenal Gastrointestinal Stromal Tumor Treated with Multimodality Managements]. Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:3 Topics: Antineoplastic Agents; Combined Modality Therapy; Drug Resistance, Neoplasm; Duodenal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Male; Middle Aged; Pyrroles; Sunitinib	2018
Imatinib and liver toxicity. BMJ case reports, 2018, Dec-07, Volume: 11, Issue:1 Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Duodenal Neoplasms; Female; Gastrointestinal Stromal Tumors; Glucocorticoids; Humans; Imatinib Mesylate; Liver Function Tests; Methylprednisolone; Middle Aged; Protein Kinase Inhibitors; Treatment Outcome	2018
Subsequent intra-abdominal fibromatosis mimicking recurrent gastrointestinal stromal tumor. Diagnostic pathology, 2013, Jul-31, Volume: 8 Topics: Antineoplastic Agents; Benzamides; Diagnostic Errors; Digestive System Surgical Procedures; Duodenal Neoplasms; Fibromatosis, Abdominal; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Predictive Value of Tests; Pyrimidines; Reoperation; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Unnecessary Procedures	2013
[Patient with bulky duodenum GIST became complete resection possible after primary systemic therapy: a case report]. Fukuoka igaku zasshi = Hukuoka acta medica, 2013, Volume: 104, Issue:12 Topics: Aged; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Digestive System Surgical Procedures; Duodenal Neoplasms; Duodenum; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Neoplasm Invasiveness; Piperazines; Preoperative Care; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome	2013
Successful treatment of bleeding large duodenal gastrointestinal stromal tumour in a patient under dual antiplatelet therapy after recent drug-eluting coronary stent implantation. BMJ case reports, 2014, Apr-28, Volume: 2014 Topics: Aged; Aspirin; Benzamides; Chemotherapy, Adjuvant; Clopidogrel; Coronary Stenosis; Drug-Eluting Stents; Duodenal Neoplasms; Gastrointestinal Hemorrhage; Gastrointestinal Stromal Tumors; Hemostatic Techniques; Humans; Imatinib Mesylate; Male; Neoadjuvant Therapy; Piperazines; Platelet Aggregation Inhibitors; Pyrimidines; Ticlopidine	2014
Clinicopathologic analysis of gastrointestinal stromal tumors in duodenum and small intestine. World journal of surgery, 2015, Volume: 39, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Duodenal Neoplasms; Female; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Imatinib Mesylate; Jejunal Neoplasms; Male; Middle Aged; Mitotic Index; Neoplasm Staging; Piperazines; Pyrimidines; Retrospective Studies; Rupture, Spontaneous; Survival Analysis; Survival Rate; Young Adult	2015
[Clinicopathological analysis of 80 patients with duodenum gastrointestinal stromal tumors]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 2015, Volume: 18, Issue:1 Topics: Abdominal Pain; Benzamides; Duodenal Neoplasms; Female; Gastrointestinal Hemorrhage; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Pancreaticoduodenectomy; Piperazines; Prognosis; Pyrimidines; Retrospective Studies; Survival Rate	2015
[A case of recurrent duodenal gastrointestinal stromal tumor resistant to imatinib and sunitinib, successfully treated with regorafenib]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Drug Resistance, Neoplasm; Duodenal Neoplasms; Fatal Outcome; Female; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Indoles; Liver Neoplasms; Middle Aged; Phenylurea Compounds; Piperazines; Pyridines; Pyrimidines; Pyrroles; Recurrence; Sunitinib; Treatment Outcome	2014
Pancreas preserving surgery for duodenal gastrointestinal stromal tumor removal. Minerva chirurgica, 2016, Volume: 71, Issue:5 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Duodenal Neoplasms; Duodenum; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Hospitals, University; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Male; Middle Aged; Organ Sparing Treatments; Pancreas; Preoperative Care; Retrospective Studies; Treatment Outcome	2016
[Review of 32 gastro-intestinal stromal tumours with CD117 antigen]. La Tunisie medicale, 2009, Volume: 87, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Duodenal Neoplasms; Female; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Imatinib Mesylate; Jejunal Neoplasms; Male; Middle Aged; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Retrospective Studies; Stomach Neoplasms; Treatment Outcome	2009
Dramatic regression and bleeding of a duodenal GIST during preoperative imatinib therapy: case report and review. World journal of surgical oncology, 2010, Jun-02, Volume: 8 Topics: Benzamides; Duodenal Neoplasms; Female; Gastrointestinal Hemorrhage; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Middle Aged; Neoadjuvant Therapy; Piperazines; Preoperative Care; Protein Kinase Inhibitors; Pyrimidines; Treatment Outcome	2010
[A case of ruptured gastrointestinal stromal tumor of the duodenum with intraabdominal bleeding]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:12 Topics: Antineoplastic Agents; Benzamides; Duodenal Neoplasms; Gastrointestinal Stromal Tumors; Hemorrhage; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Pyrimidines; Tomography, X-Ray Computed	2011
[Long-term progression-free survival after reduction surgery and postoperative low-dose imatinib administration for multiple liver metastases of duodenal gastrointestinal stromal tumor]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:6 Topics: Antineoplastic Agents; Benzamides; Combined Modality Therapy; Disease-Free Survival; Duodenal Neoplasms; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Piperazines; Pyrimidines; Tomography, X-Ray Computed	2012
Resected duodenal gastrointestinal stromal tumour with an affected margin and exon 9 mutation: adjuvant therapy. Anti-cancer drugs, 2012, Volume: 23 Suppl Topics: Adult; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; DNA Mutational Analysis; Dose-Response Relationship, Drug; Duodenal Neoplasms; Exons; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Multimodal Imaging; Mutation; Piperazines; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Pyrimidines; Tomography, X-Ray Computed	2012
Clinical, pathological and surgical characteristics of duodenal gastrointestinal stromal tumor and their influence on survival: a multi-center study. Annals of surgical oncology, 2012, Volume: 19, Issue:11 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Disease-Free Survival; Duodenal Neoplasms; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Male; Middle Aged; Mitotic Index; Pancreaticoduodenectomy; Piperazines; Proportional Hazards Models; Pyrimidines; Retrospective Studies	2012
Pancreatic extra-gastrointestinal stromal tumour masquerading as a bleeding duodenal mass. BMJ case reports, 2012, Oct-19, Volume: 2012 Topics: Antigens, CD34; Antineoplastic Agents; Benzamides; Diagnosis, Differential; Duodenal Neoplasms; Duodenum; Gastrointestinal Hemorrhage; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Mitosis; Pancreas; Pancreatic Neoplasms; Pancreaticoduodenectomy; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines	2012
Effect of a tyrosine kinase inhibitor STI571 in a patient with hepatic metastases from a duodenal gastrointestinal stromal tumor. Journal of gastroenterology, 2003, Volume: 38, Issue:7 Topics: Antineoplastic Agents; Benzamides; Duodenal Neoplasms; Female; Humans; Imatinib Mesylate; Liver Neoplasms; Middle Aged; Piperazines; Protein-Tyrosine Kinases; Pyrimidines	2003
Secondary resistance to imatinib mesylate in a patient with unresectable duodenal GIST without mutations in exons 9, 11, 13, or 17 of the c-kit protooncogene. Journal of gastroenterology, 2004, Volume: 39, Issue:9 Topics: Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Duodenal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Tomography, X-Ray Computed	2004
Gastrointestinal stromal tumors: CT and MRI findings. European radiology, 2005, Volume: 15, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Duodenal Neoplasms; Female; Gastrointestinal Stromal Tumors; Humans; Image Enhancement; Imatinib Mesylate; Intestine, Small; Liver Neoplasms; Magnetic Resonance Imaging; Male; Mesentery; Middle Aged; Peritoneal Neoplasms; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Radiographic Image Enhancement; Rectal Neoplasms; Stomach Neoplasms; Tomography, X-Ray Computed	2005
[GI hemorrhage with fulminant shock induced by jejunal gastrointestinal stromal tumor (GIST) coincident with duodenal neuroendocrine carcinoma (NET) + neurofibromatosis (NF) -- case report and review of the literature]. Zeitschrift fur Gastroenterologie, 2005, Volume: 43, Issue:3 Topics: Adult; Antineoplastic Agents; Benzamides; Carcinoma, Neuroendocrine; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Duodenal Neoplasms; Duodenum; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Jejunal Neoplasms; Neurofibromatosis 1; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Shock, Hemorrhagic; Time Factors; Tomography, Spiral Computed; Treatment Outcome	2005
[A long-term survival case with multiple liver metastases from duodenal gastrointestinal stromal tumor that was drastically reduced by the treatment with imatinib]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:11 Topics: Adult; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Duodenal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Pancreaticoduodenectomy; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Treatment Outcome	2005
Long-term survival of a case with multiple liver metastases from duodenal gastrointestinal stromal tumor drastically reduced by the treatment with imatinib and hepatectomy. World journal of gastroenterology, 2006, May-07, Volume: 12, Issue:17 Topics: Adult; Antineoplastic Agents; Benzamides; Duodenal Neoplasms; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Liver; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Survivors	2006
[Duodenal gastrointestinal stromal tumors. Report of a case]. Revista medica de Chile, 2006, Volume: 134, Issue:4 Topics: Aged; Antineoplastic Agents; Benzamides; Duodenal Neoplasms; Duodenal Ulcer; Gastrointestinal Hemorrhage; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Pancreaticoduodenectomy; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Radiography; Recurrence	2006
Imatinib in the management of multiple gastrointestinal stromal tumors associated with a germline KIT K642E mutation. Archives of pathology & laboratory medicine, 2007, Volume: 131, Issue:9 Topics: Antineoplastic Agents; Benzamides; Duodenal Neoplasms; Esophageal Neoplasms; Exons; Gastrointestinal Stromal Tumors; Germ-Line Mutation; Humans; Imatinib Mesylate; Male; Middle Aged; Pedigree; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Rectal Neoplasms; Stomach Neoplasms	2007
Simple segmental resection of the second portion of the duodenum for the treatment of gastrointestinal stromal tumors. Langenbeck's archives of surgery, 2008, Volume: 393, Issue:4 Topics: Aged; Anastomosis, Roux-en-Y; Benzamides; Duodenal Neoplasms; Duodenum; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Minimally Invasive Surgical Procedures; Neoadjuvant Therapy; Piperazines; Pyrimidines; Tomography, X-Ray Computed	2008
Successful resection of an advanced duodenal gastrointestinal stromal tumor after down-staging with imatinib: report of a case. Surgery today, 2007, Volume: 37, Issue:12 Topics: Adult; Antineoplastic Agents; Benzamides; Diagnosis, Differential; Dose-Response Relationship, Drug; Duodenal Neoplasms; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreaticoduodenectomy; Piperazines; Positron-Emission Tomography; Protein-Tyrosine Kinases; Pyrimidines; Tomography, X-Ray Computed	2007
[Successful treatment of huge peritoneal metastasis from duodenal gastrointestinal stromal tumor resistant for imatinib mesylate]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:12 Topics: Adult; Benzamides; Drug Resistance, Neoplasm; Duodenal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Peritoneal Neoplasms; Piperazines; Pyrimidines; Tomography, X-Ray Computed	2007